Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Bristol-Myers Squibb Company, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Centene Corporation May 12, 202693.8%
-
96.3%
-
Bristol-Myers Squibb Company May 5, 202696.9%
-
97.3%
-
Centene Corporation May 13, 202595.2%
-
Bristol-Myers Squibb Company May 6, 202598.5%
-
98.8%
-
Centene Corporation May 14, 202497.6%
-
Bristol-Myers Squibb Company May 7, 202495.9%
-
Centene Corporation May 10, 202396.6%
-
Bristol-Myers Squibb Company May 2, 202394.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 30, 2026 | Centene Corporation | Grant or award | +583 | — | — |
| Jun 30, 2026 | Centene Corporation | Grant or award | +465 | — | — |
| May 12, 2026 | Centene Corporation | Grant or award | +3,992 | — | — |
| Mar 31, 2026 | Centene Corporation | Grant or award | +943 | — | — |
| Dec 31, 2025 | Centene Corporation | Grant or award | +608 | — | — |
| Sep 30, 2025 | Centene Corporation | Grant or award | +710 | — | — |
| Jul 28, 2025 | Centene Corporation | Open-market purchase | +9,000 | $27.62 | $248,580 |
| Jun 30, 2025 | Centene Corporation | Grant or award | +463 | — | — |
| May 13, 2025 | Centene Corporation | Grant or award | +3,579 | — | — |
| Mar 31, 2025 | Centene Corporation | Grant or award | +416 | — | — |
| Dec 31, 2024 | Centene Corporation | Grant or award | +414 | — | — |
| Dec 13, 2024 | Centene Corporation | Open-market purchase | +5,000 | $58.86 | $294,300 |
| Sep 30, 2024 | Centene Corporation | Grant or award | +335 | — | — |
| Jun 30, 2024 | Centene Corporation | Grant or award | +377 | — | — |
| May 14, 2024 | Centene Corporation | Grant or award | +2,916 | — | — |
Questions about Theodore R. Samuels II
What boards is Theodore R. Samuels II on?
Theodore R. Samuels II sits on the boards of Bristol-Myers Squibb Company, Centene Corporation and Iron Mountain Incorporated (Delaware)Common Stock REIT.
How long has Theodore R. Samuels II served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.